Similar articles

• Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.

  Schembri S, Williamson PA, Short PM, Singanayagam A, Akram A, Taylor J, Singanayagam A, Hill AT, Chalmers JD. Schembri S, et al. BMJ. 2013 Mar 20;346:f1235. doi: 10.1136/bmj.f1235. BMJ. 2013. PMID: 23525864
• Acute coronary syndrome secondary to clarithromycin: the first case and review of the literature.

  Bilgin M, Akyel A, Doğan M, Sunman H, Yeter E. Bilgin M, et al. Turk Kardiyol Dern Ars. 2014 Jul;42(5):461-3. doi: 10.5543/tkda.2014.92891. Turk Kardiyol Dern Ars. 2014. PMID: 25080953
• Comparative study of the efficacy and tolerance of azithromycin versus clarithromycin in the treatment of community-acquired pneumonia in adults.

  Sopena N, Martínez-Vázquez C, Rodríguez-Suárez JR, Segura F, Valencia A, Sabrià M. Sopena N, et al. J Chemother. 2004 Feb;16(1):102-3. doi: 10.1179/joc.2004.16.1.102. J Chemother. 2004. PMID: 15078008 Clinical Trial. No abstract available.
• Acute pancreatitis after a course of clarithromycin.

  Schouwenberg BJ, Deinum J. Schouwenberg BJ, et al. Neth J Med. 2003 Jul;61(7):266-7. Neth J Med. 2003. PMID: 14567525
• Immune agranulocytosis and clarithromycin.

  Jacobs P, Conforti A, Wood L, Kiuru A, Jones GO, Woolf D. Jacobs P, et al. Hematology. 2004 Aug;9(4):291-6. doi: 10.1080/10245330410001714220. Hematology. 2004. PMID: 15621737 Review. No abstract available.